pubmed-article:17673465 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17673465 | lifeskim:mentions | umls-concept:C0020792 | lld:lifeskim |
pubmed-article:17673465 | lifeskim:mentions | umls-concept:C0005821 | lld:lifeskim |
pubmed-article:17673465 | lifeskim:mentions | umls-concept:C0016011 | lld:lifeskim |
pubmed-article:17673465 | lifeskim:mentions | umls-concept:C0037083 | lld:lifeskim |
pubmed-article:17673465 | lifeskim:mentions | umls-concept:C0031621 | lld:lifeskim |
pubmed-article:17673465 | lifeskim:mentions | umls-concept:C0542341 | lld:lifeskim |
pubmed-article:17673465 | lifeskim:mentions | umls-concept:C1710082 | lld:lifeskim |
pubmed-article:17673465 | lifeskim:mentions | umls-concept:C0001516 | lld:lifeskim |
pubmed-article:17673465 | lifeskim:mentions | umls-concept:C1710548 | lld:lifeskim |
pubmed-article:17673465 | lifeskim:mentions | umls-concept:C0441712 | lld:lifeskim |
pubmed-article:17673465 | lifeskim:mentions | umls-concept:C1998811 | lld:lifeskim |
pubmed-article:17673465 | pubmed:issue | 39 | lld:pubmed |
pubmed-article:17673465 | pubmed:dateCreated | 2007-9-24 | lld:pubmed |
pubmed-article:17673465 | pubmed:abstractText | Phosphoinositide (PI) 3-kinases play an important role in regulating the adhesive function of a variety of cell types through affinity modulation of integrins. Two type I PI 3-kinase isoforms (p110 beta and p110 gamma) have been implicated in G(i)-dependent integrin alpha(IIb)beta(3) regulation in platelets, however, the mechanisms by which they coordinate their signaling function remains unknown. By employing isoform-selective PI 3-kinase inhibitors and knock-out mouse models we have identified a unique mechanism of PI 3-kinase signaling co-operativity in platelets. We demonstrate that p110 beta is primarily responsible for G(i)-dependent phosphatidylinositol 3,4-bisphosphate (PI(3,4)P(2)) production in ADP-stimulated platelets and is linked to the activation of Rap1b and AKT. In contrast, defective integrin alpha(IIb)beta(3) activation in p110 gamma(-/-) platelets was not associated with alterations in the levels of PI(3,4)P(2) or active Rap1b/AKT. Analysis of the effects of active site pharmacological inhibitors confirmed that p110 gamma principally regulated integrin alpha(IIb)beta(3) activation through a non-catalytic signaling mechanism. Inhibition of the kinase function of PI 3-kinases, combined with deletion of p110 gamma, led to a major reduction in integrin alpha(IIb)beta(3) activation, resulting in a profound defect in platelet aggregation, hemostatic plug formation, and arterial thrombosis. These studies demonstrate a kinase-independent signaling function for p110 gamma in platelets. Moreover, they demonstrate that the combined catalytic and non-catalytic signaling function of p110 beta and p110 gamma is critical for P2Y(12)/G(i)-dependent integrin alpha(IIb)beta(3) regulation. These findings have potentially important implications for the rationale design of novel antiplatelet therapies targeting PI 3-kinase signaling pathways. | lld:pubmed |
pubmed-article:17673465 | pubmed:language | eng | lld:pubmed |
pubmed-article:17673465 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17673465 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17673465 | pubmed:month | Sep | lld:pubmed |
pubmed-article:17673465 | pubmed:issn | 0021-9258 | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:SalemHatem... | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:JacksonShaun... | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:ManginPierreP | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:MaxwellMhairi... | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:RewcastleGord... | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:Schoenwaelder... | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:GachetChristi... | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:AndersonKaren... | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:OnoAkikoA | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:TurnbullShann... | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:KauffensteinG... | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:KendallJackie... | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:SturgeonShare... | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:ChanSiew... | lld:pubmed |
pubmed-article:17673465 | pubmed:author | pubmed-author:MulchandaniMe... | lld:pubmed |
pubmed-article:17673465 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17673465 | pubmed:day | 28 | lld:pubmed |
pubmed-article:17673465 | pubmed:volume | 282 | lld:pubmed |
pubmed-article:17673465 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17673465 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17673465 | pubmed:pagination | 28648-58 | lld:pubmed |
pubmed-article:17673465 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:meshHeading | pubmed-meshheading:17673465... | lld:pubmed |
pubmed-article:17673465 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17673465 | pubmed:articleTitle | Identification of a unique co-operative phosphoinositide 3-kinase signaling mechanism regulating integrin alpha IIb beta 3 adhesive function in platelets. | lld:pubmed |
pubmed-article:17673465 | pubmed:affiliation | Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct (AMREP), 89 Commercial Road, Melbourne, Victoria, Australia. | lld:pubmed |
pubmed-article:17673465 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17673465 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:18441 | entrezgene:pubmed | pubmed-article:17673465 | lld:entrezgene |
entrez-gene:18707 | entrezgene:pubmed | pubmed-article:17673465 | lld:entrezgene |
entrez-gene:30955 | entrezgene:pubmed | pubmed-article:17673465 | lld:entrezgene |
entrez-gene:70839 | entrezgene:pubmed | pubmed-article:17673465 | lld:entrezgene |
entrez-gene:74769 | entrezgene:pubmed | pubmed-article:17673465 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17673465 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17673465 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17673465 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17673465 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17673465 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17673465 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17673465 | lld:pubmed |